Camber Capital Management LP Ironwood Pharmaceuticals Inc Transaction History

Camber Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $31.8 Million - $38.6 Million	-3,000,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $27.2 Million - $34.9 Million	-2,500,000 Reduced 45.45%	3,000,000 $35 Million
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $23.8 Million - $27.8 Million	-2,000,000 Reduced 26.67%	5,500,000 $71.8 Million
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $2.26 Million - $3.05 Million	250,000 Added 3.45%	7,500,000 $85.4 Million
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $6.74 Million - $8.06 Million	750,000 Added 11.54%	7,250,000 $65.2 Million
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $59.4 Million - $77.8 Million	6,500,000 New	6,500,000 $67.1 Million

236

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $607M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.